Work

Durable efficacy of cladribine tablets in patients with multiple sclerosis: analysis of relapse rates and relapse-free patients in the CLARITY and CLARITY Extension studies (P6.353)

Year: 2017

Type: article

Source: Neurology

DOI: 10.1212/wnl.88.16_supplement.p6.353

Authors: Per Soelberg-Sorensen, Gavin Giovannoni, Giancarlo Comi, Stuart Cook, Kottil Rammohan, Peter Rieckmann, Patrick Vermersch, Christine Hicking, Abidemi Adeniji, Fernando Dangond

Institutions: University of Copenhagen, Queen Mary University of London, Blizard Institute, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Rutgers, The State University of New Jersey, Rutgers New Jersey Medical School, Ohio State University Hospital, Sozialstiftung Bamberg, Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, Lille Inflammation Research International Center, Merck KGaA, Darmstadt (Germany), EMD Serono, Inc. (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2808874540

FWCI:

Cites:

Cited by:

Related to: 10